BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8935178)

  • 1. A dapsone-induced blood dyscrasia in the mouse: evidence for the role of an active metabolite.
    Ahmadi M; Khalaf LF; Smith HJ; Nicholls PJ
    J Pharm Pharmacol; 1996 Feb; 48(2):228-32. PubMed ID: 8935178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of dapsone-induced methaemoglobinaemia in the rat isolated perfused liver.
    Coleman MD; Hoaksey PE; Breckenridge AM; Park BK
    J Pharm Pharmacol; 1990 May; 42(5):302-7. PubMed ID: 1976775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of dapsone-induced methaemoglobinaemia by cimetidine in the rat during chronic dapsone administration.
    Coleman MD; Tingle MD; Park BK
    J Pharm Pharmacol; 1991 Mar; 43(3):186-90. PubMed ID: 1675276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of H(2)-receptor antagonists on dapsone-induced methaemoglobinaemia in rats.
    Malfará WR; Pereira CP; Santos AC; Queiroz RH
    Pharmacol Res; 2002 Apr; 45(4):269-73. PubMed ID: 12030789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients.
    Coleman MD; Rhodes LE; Scott AK; Verbov JL; Friedmann PS; Breckenridge AM; Park BK
    Br J Clin Pharmacol; 1992 Sep; 34(3):244-9. PubMed ID: 1389948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dapsone-induced methaemoglobinaemia].
    Rytter D; Mrgan M
    Ugeskr Laeger; 2013 Nov; 175(46):2799-800. PubMed ID: 24629319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of dapsone-induced methaemoglobinaemia by cimetidine in the presence of trimethoprim in the rat.
    Coleman MD; Russell RM; Tingle MD; Park BK
    J Pharm Pharmacol; 1992 Feb; 44(2):114-8. PubMed ID: 1352810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation of the role of metabolism in dapsone-induced methaemoglobinaemia using a two compartment in vitro test system.
    Tingle MD; Coleman MD; Park BK
    Br J Clin Pharmacol; 1990 Dec; 30(6):829-38. PubMed ID: 2288829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cimetidine and dapsone-mediated methaemoglobinaemia.
    Mehta M
    Anaesthesia; 2007 Nov; 62(11):1188. PubMed ID: 17924910
    [No Abstract]   [Full Text] [Related]  

  • 10. Dapsone-induced methhaemoglobinaemia: a source of diagnostic confusion.
    Craig D; Cadden IS; Gormley WP; Riley MS; Jones FG; McMullin MF
    Int J Clin Pract; 2000 Apr; 54(3):194-6. PubMed ID: 10829363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of cimetidine as a selective inhibitor of dapsone N-hydroxylation in man.
    Coleman MD; Scott AK; Breckenridge AM; Park BK
    Br J Clin Pharmacol; 1990 Nov; 30(5):761-7. PubMed ID: 2271376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dapsone toxicity: some current perspectives.
    Coleman MD
    Gen Pharmacol; 1995 Nov; 26(7):1461-7. PubMed ID: 8690232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cimetidine improves the therapeutic/toxic ratio of dapsone in patients on chronic dapsone therapy.
    Rhodes LE; Tingle MD; Park BK; Chu P; Verbov JL; Friedmann PS
    Br J Dermatol; 1995 Feb; 132(2):257-62. PubMed ID: 7888363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of preincubation with cimetidine on the N-hydroxylation of dapsone by human liver microsomes.
    Tingle MD; Coleman MD; Park BK
    Br J Clin Pharmacol; 1991 Jul; 32(1):120-3. PubMed ID: 1888631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very late recovery of dapsone-induced methemoglobinemia.
    Wieringa A; Bethlehem C; Hoogendoorn M; van der Maten J; van Roon EN
    Clin Toxicol (Phila); 2014 Jan; 52(1):80-1. PubMed ID: 24308869
    [No Abstract]   [Full Text] [Related]  

  • 16. Symptomatic rebound methaemoglobinaemia after treatment with dapsone.
    Jonkers BRP; Cobanoglu G; Blok EJ; Köbben JJ; van der Helm MW; van Hoof IJAM; Tintu AN; Bethlehem C; Versmissen J
    Neth J Med; 2020 Sep; 78(5):277-281. PubMed ID: 33093248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dapsone: modes of action, toxicity and possible strategies for increasing patient tolerance.
    Coleman MD
    Br J Dermatol; 1993 Nov; 129(5):507-13. PubMed ID: 8251346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factitious methemoglobinemia.
    Carr KM; Elias L; Caruana LC; Rabinowitz I
    Am J Hematol; 1999 Nov; 62(3):196-7. PubMed ID: 10539888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of acetaminophen oxidation and toxicity by cimetidine and other histamine H2-receptor antagonists in vivo and in vitro in the rat and in man.
    Mitchell MC; Schenker S; Speeg KV
    J Clin Invest; 1984 Feb; 73(2):383-91. PubMed ID: 6142056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative cyanosis: a case of dapsone-induced methaemoglobinaemia.
    Mayo W; Leighton K; Robertson B; Ruedy J
    Can J Anaesth; 1987 Jan; 34(1):79-82. PubMed ID: 3829290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.